LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,130,000 | +2073.1% | 7,317 | +1825.5% | 0.02% | +2300.0% |
| Q3 2021 | $52,000 | +6.1% | 380 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $49,000 | -98.0% | 380 | -97.7% | 0.00% | -97.8% |
| Q1 2021 | $2,490,000 | +6816.7% | 16,338 | +4315.7% | 0.05% | +4500.0% |
| Q4 2020 | $36,000 | +176.9% | 370 | +168.1% | 0.00% | – |
| Q3 2020 | $13,000 | -99.9% | 138 | -99.8% | 0.00% | -100.0% |
| Q3 2018 | $20,177,000 | +37.8% | 73,513 | +4.0% | 1.24% | +33.9% |
| Q2 2018 | $14,645,000 | +106.9% | 70,692 | +65.0% | 0.92% | +38.3% |
| Q1 2018 | $7,077,000 | – | 42,854 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |